Loading…

Rapid evolutionary response to a transmissible cancer in Tasmanian devils

Although cancer rarely acts as an infectious disease, a recently emerged transmissible cancer in Tasmanian devils ( Sarcophilus harrisii ) is virtually 100% fatal. Devil facial tumour disease (DFTD) has swept across nearly the entire species’ range, resulting in localized declines exceeding 90% and...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2016-08, Vol.7 (1), p.12684-12684, Article 12684
Main Authors: Epstein, Brendan, Jones, Menna, Hamede, Rodrigo, Hendricks, Sarah, McCallum, Hamish, Murchison, Elizabeth P., Schönfeld, Barbara, Wiench, Cody, Hohenlohe, Paul, Storfer, Andrew
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although cancer rarely acts as an infectious disease, a recently emerged transmissible cancer in Tasmanian devils ( Sarcophilus harrisii ) is virtually 100% fatal. Devil facial tumour disease (DFTD) has swept across nearly the entire species’ range, resulting in localized declines exceeding 90% and an overall species decline of more than 80% in less than 20 years. Despite epidemiological models that predict extinction, populations in long-diseased sites persist. Here we report rare genomic evidence of a rapid, parallel evolutionary response to strong selection imposed by a wildlife disease. We identify two genomic regions that contain genes related to immune function or cancer risk in humans that exhibit concordant signatures of selection across three populations. DFTD spreads between hosts by suppressing and evading the immune system, and our results suggest that hosts are evolving immune-modulated resistance that could aid in species persistence in the face of this devastating disease. A recently emerged infectious cancer has caused the near extinction of the Tasmanian devil, but some populations persist. Here, Epstein et al . provide evidence for possible resistance via rapid evolution in two genomic regions that contain cancer-related immune response genes.
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms12684